All News

What began as an awareness campaign—men sporting mustaches in November in support of men's health—now has spurred one of the largest investments in improving the quality of life for men with prostate cancer.

To further the goal of every survivor receiving a survivorship care plan, the American Society of Clinical Oncology unveiled a new two-page template, updated from its 2006 original.

Why is November not named an "awareness month?" Because stomach cancer isn't only about awareness.

The SCP discussion also allows time to determine if the survivor needs rehabilitation to regain strength and conditioning.

The numbers of those who will be affected by long-term and late effects are difficult to determine because, in many cases, each cancer or treatment is accompanied by its own list of issues, which survivors may or may not experience.

The vision that oncology professionals have for their patients after treatment is that they enjoy long, healthy lives both mentally and physically.

The FDA approves Cyramza (ramucirumab) in combination with paclitaxel for the treatment of advanced gastric cancer or GEJ adenocarcinoma.

Cancer-free days include ordinary, fun simple moments of joy

A consensus has emerged that palliative care should not be seen as end-of-life care but is best deployed early to help patients and their caregivers manage symptoms throughout the cancer treatment trajectory.

Ask a number of people how they received unsettling news about their cancer and most will remember in striking detail, but a doctor-led program aims to help physicians learn how to break bad news better. Will it help?

The FDA has granted a breakthrough therapy designation to the immunotherapy drug Keytruda (pembrolizumab) for the treatment of patients with non-small cell lung cancer.

In September, The Ohio State University Comprehensive Cancer Center, collaborating with the Department of Emergency Medicine, opened a fully integrated cancer emergency department at the new James Cancer Hospital to care for patients who develop emergencies caused by their cancers.

Preliminary data from a phase 2 trial demonstrates that a combination of the PARP inhibitor veliparib and chemotherapy benefits patients with squamous cell non-small cell lung cancer.

Being a parent affects EVERY decision in my life, even the ones regarding my cancer care.

Recently approved Akynzeo prevents common side effect with a combination approach.

In a recent study, patients with terminal cancer shared how being parents of young children impacted their treatment decisions.

Lobular carcinoma in situ, or LCIS, is considered a risk factor for invasive cancer. 

Science could help determine the best treatment for individual patients.ÂÂ

Exercise and nutrition intervention for patients with cancer could help with symptoms from treatment.

Overattentive caregivers can undermine patient recovery.

Be prepared, cautious and report certain symptoms to your medical team immediately.

Because lymphedema can occur years after surgery, it's important to be aware of the area where the lymph nodes were removed or radiated.

Early rather than late palliative care support provided benefits to family caregivers as well as patients.

An open conversation about goals of treatment is the first step after diagnosis.